<code id='ABD4AC86E9'></code><style id='ABD4AC86E9'></style>
    • <acronym id='ABD4AC86E9'></acronym>
      <center id='ABD4AC86E9'><center id='ABD4AC86E9'><tfoot id='ABD4AC86E9'></tfoot></center><abbr id='ABD4AC86E9'><dir id='ABD4AC86E9'><tfoot id='ABD4AC86E9'></tfoot><noframes id='ABD4AC86E9'>

    • <optgroup id='ABD4AC86E9'><strike id='ABD4AC86E9'><sup id='ABD4AC86E9'></sup></strike><code id='ABD4AC86E9'></code></optgroup>
        1. <b id='ABD4AC86E9'><label id='ABD4AC86E9'><select id='ABD4AC86E9'><dt id='ABD4AC86E9'><span id='ABD4AC86E9'></span></dt></select></label></b><u id='ABD4AC86E9'></u>
          <i id='ABD4AC86E9'><strike id='ABD4AC86E9'><tt id='ABD4AC86E9'><pre id='ABD4AC86E9'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:2
          Adam's take main illustration
          Molly Ferguson/STAT

          This week, a preview of the TUDCA study in ALS and thoughts on how it might impact Amylyx Pharmaceuticals. Also, I chatted with CRISPR Therapeutics CEO Sam Kulkarni about its new investor. Read to the end for some burning questions, random thoughts.

          The next ALS data readout — overdue but important

          A European academic consortium is expected to announce results soon from a clinical trial investigating the use of a widely available nutritional supplement called tauroursodeoxycholic acid, or TUDCA, in people living with ALS. The outcome of the TUDCA-ALS study could have implications for Amylyx Pharmaceuticals, because TUDCA is one of the two main ingredients in Relyvrio, the company’s approved drug for ALS.

          advertisement

          In a recent interview at Amylyx’s Kendall Square headquarters, co-CEOs Justin Klee and Josh Cohen mostly downplayed the suggestion that results from the randomized, placebo-controlled TUDCA study might affect Relyvrio negatively, or even positively.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          He's 19 months old and has one of the world’s rarest diseases
          He's 19 months old and has one of the world’s rarest diseases

          LucasGuo,aboywitharareneurologicalconditioncalledZTTK,isencouragedbyhisfather,NathanGuo,andmother,Ad

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          Fetal cell organoids grown from amniotic fluid, study finds

          AdobeAsafetusdevelops,itsbodyisbathedinamnioticfluid:awarm,saltysoupofnutrients,hormones,andantibodi